Streck Emilio L, Vieira Paula S, Wannmacher Clóvis M D, Dutra-Filho Carlos S, Wajner Moacir, Wyse Angela T S
Departamento de Bioquímica, ICBS, Universidade Federal do Rio Grande do Sul, Rua Ramiro Barcelos, Porto Alegre, RS, Brazil.
Metab Brain Dis. 2003 Jun;18(2):147-54. doi: 10.1023/a:1023815119931.
Homocystinuria is an inherited metabolic disease characterized biochemically by increased blood and brain levels of homocysteine caused by severe deficiency of cystathionine beta-synthase activity. Affected patients present mental retardation, seizures, and atherosclerosis. Oxidative stress plays an important role in the pathogenesis of many neurodegenerative and vascular diseases, such Alzheimer's disease, stroke, and atherosclerosis. However, the mechanisms underlying the neurological damage characteristic of homocystinuria are still poorly understood. To evaluate the involvement of oxidative stress on the neurological dysfunction present in homocystinuria, we measured thiobarbituric acid reactive substances (TBARS), an index of lipid peroxidation, and total radical-trapping antioxidant potential (TRAP) and antioxidant enzyme activities (superoxide dismutase, catalase, and glutathione peroxidase) in rat hippocampus in the absence (controls) or in the presence of homocysteine (10-500 microM) in vitro. We demonstrated that homocysteine significantly increases TBARS and decreases TRAP, both in a dose-dependent manner, but did not change antioxidant enzymes. Our results suggest that oxidative stress is involved in the neurological dysfunction of homocystinuria. However, further studies are necessary to confirm and extend our findings to the human condition and also to determine whether antioxidant therapy may be of benefit to these patients.
同型胱氨酸尿症是一种遗传性代谢疾病,其生化特征是由于胱硫醚β-合酶活性严重缺乏导致血液和大脑中同型半胱氨酸水平升高。受影响的患者表现出智力迟钝、癫痫发作和动脉粥样硬化。氧化应激在许多神经退行性疾病和血管疾病(如阿尔茨海默病、中风和动脉粥样硬化)的发病机制中起重要作用。然而,同型胱氨酸尿症特有的神经损伤潜在机制仍知之甚少。为了评估氧化应激在同型胱氨酸尿症神经功能障碍中的作用,我们在体外测量了大鼠海马体中硫代巴比妥酸反应性物质(TBARS,脂质过氧化指标)、总自由基捕获抗氧化能力(TRAP)以及抗氧化酶活性(超氧化物歧化酶、过氧化氢酶和谷胱甘肽过氧化物酶),实验分为不存在同型半胱氨酸(对照组)和存在同型半胱氨酸(10 - 500微摩尔)的情况。我们证明,同型半胱氨酸显著增加TBARS并降低TRAP,两者均呈剂量依赖性,但不改变抗氧化酶活性。我们的结果表明,氧化应激与同型胱氨酸尿症的神经功能障碍有关。然而,需要进一步研究来证实并将我们的发现扩展至人类情况,同时确定抗氧化治疗是否对这些患者有益。